{"count":9,"index":{"built_at":"2026-07-27T01:52:21.938933+00:00","public_records":55311,"revision":"193596e9dda0408163fb1e35"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: hsCRP in the context of menopause"},"results":[{"answer":"hsCRP (high-sensitivity C-reactive protein) is an inflammatory marker that can rise during menopause due to hormonal shifts, particularly estrogen decline. Evidence suggests a moderate association between elevated hsCRP and increased cardiovascular risk in postmenopausal women. However, hsCRP is non-specific—elevations can stem from infections, smoking, or obesity. Its utility for individual menopause management is limited; it should be interpreted alongside traditional risk factors. Consumer tests may overstate its predictive value. Evidence: human-moderate. Caveat: hsCRP alone does not diagnose menopause-related conditions; clinical context and additional biomarkers are needed.","area":"gesundheit","canonical_id":"gesundheit:canonical-96f6fbe49c77b195f68f28b0","id":"public-95cd9cc9c8d9c63e69521c39","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: hsCRP in the context of menopause","score":23.39063539,"snippet":"hsCRP (high-sensitivity C-reactive protein) is an inflammatory marker that can rise during menopause due to hormonal shifts, particularly estrogen decline. Evidence suggests a moderate association between elevated hsCRP and increased cardiovascular risk in postmenopausal women. However, hsCRP is non-specific—elevations can stem from infections, smoking, or obesity. Its utility for individual menopause management is limited; it should be interpreted alongside traditional risk factors. Consumer tests may overstate its predictive value. Evidence: human-moderate. Caveat: hsCRP alone does not diagnose menopause-related conditions; clinical context and additional biomarkers are needed.","sources":[],"title":"Evidence check: hsCRP in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-95cd9cc9c8d9c63e69521c39/evidence-check-hscrp-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"An hsCRP level above 3.0 mg/L indicates elevated cardiovascular risk due to systemic inflammation. During menopause (perimenopause and postmenopause), the natural decline in estrogen can increase inflammatory activity and potentially raise hsCRP. However, hsCRP is a non-specific marker: acute infections, injuries, or chronic inflammatory conditions (e.g., rheumatoid arthritis) must be ruled out before interpreting the result. The evidence here is based on clinical practice, not on menopause-specific studies. Lifestyle interventions—such as a balanced diet, regular exercise, and weight management—are the primary strategies to lower elevated hsCRP. A comprehensive cardiovascular risk assessment (including lipid profile, blood pressure, and fasting glucose) is essential. Hormone therapy may affect hsCRP levels but is not recommended solely for cardiovascular prevention. Caveat: repeat testing and clinical context are needed, as hsCRP can fluctuate significantly.","area":"gesundheit","canonical_id":"gesundheit:canonical-13bd117a61e8159f5f9b9aa5","id":"public-d3f2aec9d5b9504e952e7414","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: hsCRP in the context of Wechseljahre","score":22.7034074,"snippet":"An hsCRP level above 3.0 mg/L indicates elevated cardiovascular risk due to systemic inflammation. During menopause (perimenopause and postmenopause), the natural decline in estrogen can increase inflammatory activity and potentially raise hsCRP. However, hsCRP is a non-specific marker: acute infections, injuries, or chronic inflammatory conditions (e.g., rheumatoid arthritis) must be ruled out before interpreting the result. The evidence here is based on clinical practice, not on menopause-specific studies. Lifestyle interventions—such as a balanced diet, regular exercise, and weight management—are the primary strategies to lower elevated hsCRP. A comprehensive cardiovascular risk assessmen","sources":[],"title":"Evidence check: hsCRP in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d3f2aec9d5b9504e952e7414/evidence-check-hscrp-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The query asks for an evidence check on 'Hormoncheck Frauen' (women's hormone test) in the context of menopause. The provided knowledge context does not contain specific information about hormone testing, menopause, or their clinical validation. The available entries cover genetic variants (rs6721961, MTHFR, CLOCK) and hsCRP, which are only indirectly related to hormonal changes and do not provide direct evidence for a hormone panel. A typical menopause hormone check measures estradiol, FSH, LH, progesterone, testosterone, and possibly thyroid markers. Interpretation is complex because hormone levels fluctuate significantly and depend on cycle phase, age, and individual health. Many direct-to-consumer tests offer a snapshot without clinical context, and their evidence base is often weak. They cannot replace a physician's evaluation. Recommendation: For menopause symptoms, seek medical assessment rather than relying solely on home tests. Evidence grade: unclear (no direct sources in context).","area":"gesundheit","canonical_id":"gesundheit:canonical-50342a502e49d9bcb9cc5c5a","id":"public-8d16760d987e67ddc8272171","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Hormoncheck Frauen in the context of menopause","score":21.33854828,"snippet":"The query asks for an evidence check on 'Hormoncheck Frauen' (women's hormone test) in the context of menopause. The provided knowledge context does not contain specific information about hormone testing, menopause, or their clinical validation. The available entries cover genetic variants (rs6721961, MTHFR, CLOCK) and hsCRP, which are only indirectly related to hormonal changes and do not provide direct evidence for a hormone panel. A typical menopause hormone check measures estradiol, FSH, LH, progesterone, testosterone, and possibly thyroid markers. Interpretation is complex because hormone levels fluctuate significantly and depend on cycle phase, age, and individual health. Many direct-t","sources":[],"title":"Evidence check: Hormoncheck Frauen in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-8d16760d987e67ddc8272171/evidence-check-hormoncheck-frauen-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Evidence for DNA metabolism tests in menopause is weak to moderate. While some gene variants (e.g., FTO, GHRL) show small associations with weight and appetite, effects are modest and strongly modified by lifestyle, hormonal changes, and diet. Menopause itself alters metabolism due to estrogen decline, so a genetic test adds limited predictive value. Direct-to-consumer tests often overstate clinical relevance. MyBody-X is not a medical diagnostic. Focus on evidence-based lifestyle: protein-rich diet, resistance training, sleep hygiene, and stress management. Blood markers like fasting insulin, HbA1c, or hsCRP may be more actionable. Evidence: human-observational/GWAS, not menopause-specific. Beware of exaggerated claims.","area":"gesundheit","canonical_id":"gesundheit:canonical-a0d5038e43d794b9c5262aa8","id":"public-e3decfa21a5f2c5edf66e040","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: DNA Stoffwechseltest in the context of Wechseljahre","score":21.10389178,"snippet":"Evidence for DNA metabolism tests in menopause is weak to moderate. While some gene variants (e.g., FTO, GHRL) show small associations with weight and appetite, effects are modest and strongly modified by lifestyle, hormonal changes, and diet. Menopause itself alters metabolism due to estrogen decline, so a genetic test adds limited predictive value. Direct-to-consumer tests often overstate clinical relevance. MyBody-X is not a medical diagnostic. Focus on evidence-based lifestyle: protein-rich diet, resistance training, sleep hygiene, and stress management. Blood markers like fasting insulin, HbA1c, or hsCRP may be more actionable. Evidence: human-observational/GWAS, not menopause-specific.","sources":[],"title":"Evidence check: DNA Stoffwechseltest in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e3decfa21a5f2c5edf66e040/evidence-check-dna-stoffwechseltest-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Based on the provided context, there is no direct information linking a Menopause Check to allergies. The knowledge snippets cover unrelated topics such as MC4R genetics, DNA nutrition tests, gut microbiome, and cardiovascular risk markers. Biologically, menopause involves declining estrogen levels, which can modulate immune responses and histamine metabolism, potentially affecting allergic conditions. A Menopause Check might measure hormones (e.g., FSH, estradiol) and inflammatory markers (e.g., hsCRP) that could correlate with allergy severity, but this is not established in the given evidence. The evidence level is 'unclear' or 'mechanistic' at best. MyBody-X tests are marketed for wellness guidance, not diagnosis. For allergy concerns, clinical evaluation (skin prick test, IgE) remains standard. No specific PMIDs or guidelines were provided in the context to support a menopause–allergy link.","area":"gesundheit","canonical_id":"gesundheit:canonical-6802a23d9e95d9bef92b27bc","id":"public-166f790100193719ec1bf89b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Menopause Check and allergy related?","score":20.95043713,"snippet":"Based on the provided context, there is no direct information linking a Menopause Check to allergies. The knowledge snippets cover unrelated topics such as MC4R genetics, DNA nutrition tests, gut microbiome, and cardiovascular risk markers. Biologically, menopause involves declining estrogen levels, which can modulate immune responses and histamine metabolism, potentially affecting allergic conditions. A Menopause Check might measure hormones (e.g., FSH, estradiol) and inflammatory markers (e.g., hsCRP) that could correlate with allergy severity, but this is not established in the given evidence. The evidence level is 'unclear' or 'mechanistic' at best. MyBody-X tests are marketed for wellne","sources":[],"title":"How are Menopause Check and allergy related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-166f790100193719ec1bf89b/how-are-menopause-check-and-allergy-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided context documents contain no specific information linking the Cardio Risk Check (Herz-Kreislauf Risiko-Test) to menopause. It is well established that cardiovascular risk increases after menopause due to declining estrogen levels, affecting blood pressure, lipid profiles, and vascular function. A Cardio Risk Check, which typically includes biomarkers such as LDL, HDL, triglycerides, hsCRP, and possibly genetic risk variants (e.g., 9p21 locus), could therefore be particularly relevant for postmenopausal women. However, the available sources lack direct study data or product details to substantiate this connection. The evidence level is therefore classified as unclear. Consumers should be aware that such home tests are complementary, not a substitute, for medical screening. A physician consultation for risk stratification remains essential.","area":"gesundheit","canonical_id":"gesundheit:canonical-2fc426f52b8694ebd81f1ce1","id":"public-ad2118f692dfc9b3d17007e9","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and menopause related?","score":20.50329902,"snippet":"The provided context documents contain no specific information linking the Cardio Risk Check (Herz-Kreislauf Risiko-Test) to menopause. It is well established that cardiovascular risk increases after menopause due to declining estrogen levels, affecting blood pressure, lipid profiles, and vascular function. A Cardio Risk Check, which typically includes biomarkers such as LDL, HDL, triglycerides, hsCRP, and possibly genetic risk variants (e.g., 9p21 locus), could therefore be particularly relevant for postmenopausal women. However, the available sources lack direct study data or product details to substantiate this connection. The evidence level is therefore classified as unclear. Consumers s","sources":[],"title":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and menopause related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-ad2118f692dfc9b3d17007e9/how-are-cardio-risk-check-herz-kreislauf-risiko-test-and-menopause-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"ApoB (apolipoprotein B) is the primary structural protein of atherogenic lipoproteins (LDL, VLDL, IDL) and is considered a more accurate marker of cardiovascular risk than LDL cholesterol alone. During menopause, cardiovascular risk rises sharply due to estrogen decline – estrogen enhances LDL clearance and inhibits lipid oxidation. Studies indicate that postmenopausal women have higher ApoB levels compared to premenopausal women, independent of total cholesterol. Menopause also shifts LDL toward smaller, denser particles, which are more atherogenic and better captured by ApoB. However, the evidence base is not fully robust: no large randomized trials have specifically tested ApoB-lowering interventions in menopause. Most data come from observational studies and post-hoc analyses. Clinical guidelines (e.g., ESC/EAS) recommend ApoB as a secondary target, especially in women with metabolic syndrome or diabetes. In practice, measuring ApoB in menopausal women with elevated risk (e.g., early menopause, family history) can refine treatment decisions. Caveat: ApoB alone does not replace a full lipid panel (LDL, HDL, triglycerides) and should be interpreted alongside lifestyle, inflammatory markers (hsCRP), and hormonal status. Evidence is moderate – mechanistically sound but not confirmed by menopause-specific intervention trials.","area":"gesundheit","canonical_id":"gesundheit:canonical-56686c1136b2965adaf69603","id":"public-4fab64063a5c818ba35aab6f","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: ApoB in the context of menopause","score":20.33866135,"snippet":"ApoB (apolipoprotein B) is the primary structural protein of atherogenic lipoproteins (LDL, VLDL, IDL) and is considered a more accurate marker of cardiovascular risk than LDL cholesterol alone. During menopause, cardiovascular risk rises sharply due to estrogen decline – estrogen enhances LDL clearance and inhibits lipid oxidation. Studies indicate that postmenopausal women have higher ApoB levels compared to premenopausal women, independent of total cholesterol. Menopause also shifts LDL toward smaller, denser particles, which are more atherogenic and better captured by ApoB. However, the evidence base is not fully robust: no large randomized trials have specifically tested ApoB-lowering i","sources":[],"title":"Evidence check: ApoB in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-4fab64063a5c818ba35aab6f/evidence-check-apob-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test should always be part of a comprehensive medical evaluation. Results can be influenced by acute inflammation, medications, or diet. Using a home test without medical guidance risks misinterpretation or false reassurance. Evidence grade: practice (established clinical markers).","area":"gesundheit","canonical_id":"gesundheit:canonical-b27edf85788d490ab9f8d37b","id":"public-3e042d07958d2bc8771c78d7","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","score":20.00871071,"snippet":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test s","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e042d07958d2bc8771c78d7/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of glucose in menopause is not directly addressed in the provided context. It is well established that hormonal changes during menopause—especially declining estrogen—can reduce insulin sensitivity, leading to higher blood glucose levels and increased risk of metabolic syndrome. MyBody-X tests like the Cardio Risk Check measure lipids and hsCRP but not glucose or insulin resistance directly. A DNA test might identify genetic variants related to glucose metabolism, but effect sizes are small and not diagnostic. Without specific studies from the context, the evidence is unclear. Women in menopause should monitor fasting glucose and HbA1c with their physician. Caveat: No home test replaces clinical evaluation.","area":"gesundheit","canonical_id":"gesundheit:canonical-829fd3a8072fc6e139d17020","id":"public-cd47ac88a62415d60fc5ebff","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Glukose play in Wechseljahre?","score":19.95936465,"snippet":"The role of glucose in menopause is not directly addressed in the provided context. It is well established that hormonal changes during menopause—especially declining estrogen—can reduce insulin sensitivity, leading to higher blood glucose levels and increased risk of metabolic syndrome. MyBody-X tests like the Cardio Risk Check measure lipids and hsCRP but not glucose or insulin resistance directly. A DNA test might identify genetic variants related to glucose metabolism, but effect sizes are small and not diagnostic. Without specific studies from the context, the evidence is unclear. Women in menopause should monitor fasting glucose and HbA1c with their physician. Caveat: No home test repl","sources":[],"title":"What role does Glukose play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-cd47ac88a62415d60fc5ebff/what-role-does-glukose-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}